Implant Sciences Sponsors Global Sports Management Summit

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Implant Sciences Sponsors Global Sports Management Summit

WILMINGTON, MA--(Marketwired - May 8, 2013) - Implant Sciences Corporation ( OTCQB : IMSC ), a high technology supplier of systems and sensors for homeland security and defense markets, today announced it is a supporting sponsor of the Global Sports Management Summit , which will take place on May 8 to 10 in Chicago. The Global Sports Management Summit is the premier invitation-only meeting created for senior executives from the NFL, NBA, MLB, NHL, MLS, NCAA, European Football and other professional sports globally. As a sponsor, Implant Sciences' executives will have the opportunity to engage with the key decision makers managing sporting events, venues and associated security matters.

Implant Sciences' Quantum Sniffers have been used to provide security at some of the highest profile sporting events in the world including the 2008 Beijing Olympics, the 2011 Summer Universiade Games in Shenzhen, China, and the 2012 Special Olympics in London.

"While intelligence can often uncover potential attacks and law enforcement can interdict before an attack strikes, no one method can be completely effective at a sporting venue, or any other location. Good security involves multiple layers and techniques," stated Implant Sciences' Vice President of Sales and Marketing, Dr. Darryl Jones. "At sporting events, there is one item that offers a unique security screening opportunity: the event ticket."

Quantum Sniffers are explosives trace detection systems that detect and identify threats from small amounts of explosives left behind after a person handles explosives. These traces stick to the hands and are subsequently transferred to everything an individual touches. Detectable amounts of explosives can be left on event tickets, making them a good vehicle for evaluating if someone has handled explosives.

"We are in talks with sporting events managers and are proposing a fast, non-contact method of security using our Quantum Sniffers. Our systems can scan tickets at the same time that fans present these tickets as they enter a stadium or arena, without creating a bottleneck or delay. This approach provides a combination of excellent detection performance with a strong deterrence factor," added Jones. "We believe the QS-H150 is the only ETD system in the market capable of achieving this feat, due to our continuous non-contact sampling capability."

"Our systems offer a non-intrusive and cost-effective way to add an extra layer of security at sporting events so that fans can enjoy a game with greater peace of mind. Having served to protect global events, including the Olympics, we realize Quantum Sniffers can be deployed on the home front here in the U.S. as well as abroad," stated Implant Sciences' President and CEO, Glenn D. Bolduc.

About the Quantum Sniffer™ QS-H150 Handheld Explosives Trace Detector

The Quantum Sniffer QS-H150 utilizes Ion Mobility Spectrometry (IMS) technology, providing fast, accurate detection of trace amounts of a wide variety of military, commercial, and homemade explosives. Built with no radioactive materials and featuring a low-maintenance, self-calibrating, and self-clearing design, the QS-H150 provides very high levels of operational availability. The QS-H150 has been proven to perform well in a wide variety of temperatures and challenging environments, from humid jungles to dry, sand swept deserts.

About Implant Sciences

Implant Sciences is the leader in next generation Explosives Trace Detection (ETD) technology. In January 2013, the Company became only the third ETD manufacturer, and the sole American-owned company, to have product approval from the US Transportation Security Administration. Implant Sciences has developed proprietary technologies used in its commercial explosives and drugs trace detection systems, which ship to a growing number of locations domestically and internationally. Implant Sciences' QS-H150 portable explosives trace detector has received Qualified Anti-Terrorism Technology Designation and, in addition to receiving TSA approval for air cargo screening, the Company's QS-B220 has also received a Developmental Testing & Evaluation (DT&E) Designation by the U.S. Department of Homeland Security under the Support Anti-terrorism by Fostering Effective Technology Act of 2002 (the SAFETY Act). For further details on the Company and its products, please visit the Company's website at www.implantsciences.com .

Safe Harbor Statement

This press release may contain certain "forward-looking statements," as that term is defined in the Private Securities Litigation Reform Act of 1995. Such statements are based on management's current expectations and are subject to risks and uncertainties that could cause the Company's actual results to differ materially from the forward-looking statements. Such risks and uncertainties include, but are not limited to, the risks that our explosives detection products and technologies (including any new products we may develop) may not be accepted by the Transportation Security Administration or by other U.S. or foreign government and law enforcement agencies or commercial consumers of security products; economic, political and other risks associated with international sales and operations could adversely affect our sales; our business is subject to intense competition and rapid technological change; the risks that our markets are subject to technological change and that our success depends on our ability to develop and introduce new products; and other risks and uncertainties described in our filings with the Securities and Exchange Commission, including its most recent Forms 10-K, 10-Q and 8-K. Such statements are based on management's current expectations and assumptions which could differ materially from the forward-looking statements.

Contact: Implant Sciences Corporation Company Contact: Glenn Bolduc CEO 978-752-1700 Email Contact or Investor Contact: Laurel Moody 646-810-0608 Email Contact

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Lundbeck's Board Leadership Transitions into New Era

Updated Category News Views 10

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

Continue Reading
Faith and Resilience in China: The Legacy of the Long March

Updated Category News Views 20

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Continue Reading
Tomorrowland's Shanghai Return: An Electri-Lifesaver

Updated Category News Views 24

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

Continue Reading
Antheia Secures $80M for Critical Medicine Onshoring

Updated Category News Views 22

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

Continue Reading
UEG's New Advisory Board: Elevating Patient Voices

Updated Category News Views 20

Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...

Continue Reading
ASTS Faces a Legal Countdown – Investors Take Note

Updated Category News Views 11

AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...

Continue Reading
AEVEX Faces 48-Hour Deadline for Investor Class Action

Updated Category News Views 14

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

Continue Reading

Top 5 Most Recently Viewed Articles

Understanding F5 Inc.'s Stock Performance and Valuation

Updated Category News Views 180

Analyzing F5 Inc.'s Stock Metrics In today's market, F5 Inc. (NASDAQ: FFIV) is trading at $315.70 after experiencing a slight decrease of 0.48%. Interestingly, over the past month, the company has seen its stock rise by 5.50%, and in the last year, it has impressively increased by 58.08%. This growth prompts shareholders to contemplate whether the stock's current...

Continue Reading
Jeffs’ Brands Enters Strategic Agreement for Security Tech Expansion

Updated Category News Views 127

Exploring New Horizons: Jeffs’ Brands' Non-Binding MOU The 3D, AI-Powered Technology Screens 25,000 People Per Hour—Without Stopping Them In an exciting development for Jeffs' Brands Ltd (“Jeffs’ Brands” or the “Company”) (NASDAQ: JFBR, JFBRW), a leading data-driven e-commerce firm leveraging the Amazon Marketplace, the company has announced its wholly owned...

Continue Reading
Essential Tips for Managing Chronic Back Pain and Health

Updated Category News Views 94

Understanding Pain Awareness Month September signals National Pain Awareness Month, a significant time to shed light on the challenges and treatment options for managing pain. Chronic pain impacts millions worldwide, deeply affecting day-to-day life. In particular, lower back pain is alarming, affecting over 619 million people globally according to recent statistics....

Continue Reading
Nerivio® REN Wearable Receives Approval in China for Migraine Relief

Updated Category News Views 336

Pier 88 Health and Theranica Revolutionize Migraine Treatment Pier 88 Health, a pioneer in digital health, and Theranica have announced a significant advancement in migraine treatment. Their groundbreaking product, the Nerivio® REN wearable, is now approved by China's National Medical Products Administration (NMPA), marking a pivotal moment for those suffering from this...

Continue Reading
Join the Excitement of CARNIVALE 2026 at Grace Cathedral

Updated Category News Views 198

Experience the Vibrant CARNIVALE 2026 Celebration Grace Cathedral, the cherished Episcopal landmark, is proud to announce the return of its spectacular Mardi Gras gala, CARNIVALE 2026. This exciting event is scheduled for February 13, 2026, promising to be a grand festive evening filled with joy and celebration. The Theme: Noite de Carnaval This year's theme, Noite de...

Continue Reading